References
- AACAP. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2007; 46: 267–283
- Barrett PM, Dadds MR, Rapee RM. Family treatment of childhood anxiety: A controlled trial. Journal of Consulting and Clinical Psychology 1996; 64(2)333–342
- Barrett PM, Duffy AL, Dadds MR. Cognitive-behavioral treatment of anxiety disorders in children: Long-term (6-year) follow-up. Journal of Consulting and Clinical Psychology 2001; 69(1)135–141
- Beidel DC, Turner SM, Young B. Social effectiveness therapy for children: Three-year follow-up. Journal of Consulting and Clinical Psychology 2005; 73(4)721–725
- Berman SL, Weems CF, Silverman WK. Predictors of outcome in exposure-based cognitive and behavioral treatments for phobic and anxiety disorders in children. Behavior Therapy 2000; 31(4)713–731
- Bernstein GA, Borchardt CM, Perwien AR. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. Journal of the American Academy of Child and Adolescent Psychiatry 2000; 39(3)276–283
- Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, et al. Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child & Adolescent Psychiatry 2003; 42(4)415–423
- Cartwright-Hatton S, Roberts C, Chitsabesan P. Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders. British Journal of Clinical Psychology 2004; 43(4)421–436
- Cobham VE, Dadds MR, Spence SH. The role of parental anxiety in the treatment of childhood anxiety. Journal of Consulting and Clinical Psychology 1998; 66: 893–905
- Compton SN, Burns BJ, Helen LE, Robertson E. Review of the evidence base for treatment of childhood psychopathology: Internalizing disorders. Evidence Based Mental Health 2002; 70: 1240–1266
- Compton SN, March JS, Brent D. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based medicine review. Journal of the American Academy of Child and Adolescent Psychiatry 2004; 43(8)930–959
- Dummit ES, Klein RG, Tancer NK, Asche B, Martin J. Fluoxetine treatment of children with selective mutism: An open trial. Journal of the American Academy of Child and Adolescent Psychiatry 1996; 35: 615–621
- Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-Cycloserine. CNS Drug Reviews 2006; 12(3–4)208–217
- James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database of Systematic Reviews 2005; 4: CD004690
- Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, et al. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biological Psychiatry 2007; 62(8)835–838
- Labellarte MJ, Ginsburg GS, Walkup JT. The treatment of anxiety disorders in children and adolescents. Biological Psychiatry 1999; 46(11)1567–1578
- Mendlowitz SL, Manassis K, Bradley S. Cognitive-behavioral group treatments in childhood anxiety disorders: The role of parental involvement. Journal of the American Academy of Child and Adolescent Psychiatry 1999; 38(10)1223–1229
- National Institutes of Health Clinical Trials. Child Anxiety Multimodal Study 2003, Available at www.clinicaltrials.gov, Identifier NCT00052078 accessed 29 July 2007
- Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, et al. Novel treatment approaches for refractory anxiety disorders. Depression and Anxiety 2008; in press
- Reinblatt SP, Riddle MA. The pharmacological management of childhood anxiety disorders: A review. Psychopharmacology 2007; 191(1)67–86
- The Research Units on Pediatric Psychopharmacology Anxiety Study Group (RUPP). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. New England Journal of Medicine 2001; 344(17)1279–1285
- The Research Units on Pediatric Psychopharmacology Anxiety Study Group (RUPP). Treatment of pediatric anxiety disorders: An open-label extension of the Research Units on Pediatric Psychopharmacology Anxiety Study. Journal of Child and Adolescent Psychopharmacology 2002; 12(3)175–188
- Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. American Journal of Psychiatry 2001; 158(12)2008–2014
- Silverman WK, Kurtines WM, Ginsburg GS. Contingency management, self-control, and education support in the treatment of childhood phobic disorders: A randomized clinical trial. Journal of Consulting and Clinical Psychology 1999; 67(5)675–687
- Treadwell KR, Flannery-Schroeder EC, Kendall EC. Ethnicity and gender in relation to adaptive functioning, diagnostic status, and treatment outcome in children from an anxiety clinic. Journal of Anxiety Disorders 1995; 9(5)373–384
- Weisz JR, Jensen PS. Efficacy and effectiveness of child and adolescent psychotherapy and pharmacotherapy. Mental Health Services Research 1999; 1(3)125–157
- Westra HA, Dozois DJ. Preparing clients for cognitive behavioral therapy: A randomized pilot study of motivational interviewing for anxiety. Cognitive Therapy and Research 2006; 30: 481–498
- Westra HA, Dozois DJ, Marcus M. Expectancy, homework compliance, and initial change in cognitive-behavioral therapy for anxiety. Journal of Consulting and Clinical Psychology 2007; 75(3)363–373
- Wood JJ, Piacentini JC, Southam-Gerow M. Family cognitive behavioral therapy for child anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(3)314–321